Press release
Gestational Diabetes Market Size Projected To Reach 12.9 Billion By 2034 With A Cagr Of 9%
Gestational Diabetes
What Is the Projected Growth of the Gestational Diabetes Market?
The market size for gestational diabetes has seen robust growth in recent years, with projections indicating a rise from $8.37 billion in 2024 to $9.14 billion in 2025, which represents a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this historical growth trend include heightened diabetes risk, improved precision in blood glucose level measurement, a rise in insurance providers, a larger population of diabetic patients, and a general surge in the diabetes population.
Expectations are high for substantial growth in the gestational diabetes market size over the coming years. The market is projected to reach a staggering $12.90 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth include the rising obesity rates, acceptance of cloud-based project schemes, and increased usage of related devices and applications. Additionally, unhealthy lifestyle choices leading to a spike in the prevalence of diabetes, heightened community health awareness, and escalating diabetes occurrence rates also add to this growth. The forecast period will be characterized by significant trends such as digital diabetes management applications, closed-loop control systems, diabetes management technology, enzymatic technology, and novel medical technologies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20818
What Are the Different Gestational Diabetes Market Segments?
The gestational diabetes market covered in this report is segmented -
1) By Types: Type A1, Type A2, Other Types
2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment
3) By Administration: Oral, Intravenous, Other Administrations
4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers
Subsegments:
1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes
2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes
3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp
What Are the Primary Drivers Shaping the Gestational Diabetes Market?
The rise in the obesity rate is anticipated to fuel the expansion of the gestational diabetes market. Obesity, characterized by a body mass index (BMI) of 30 or above, signals excessive body fat that could bear substantial health hazards. The surge in obesity is attributed to factors like inactive lifestyles, increased intake of high-calorie processed foods, genetic tendencies, and restricted availability of nutritious food and opportunities for exercise. Gestational diabetes interventions are vital for obese individuals due to their elevated susceptibility to insulin resistance and excessive pregnancy-related weight gain, which could result in significant issues for both the mother and the baby if left unaddressed. As per the World Health Organization, a Switzerland-based intergovernmental organization, in March 2024, about 1 in 8 people around the world were dealing with obesity in 2022, with 2.5 billion adults aged 18 and older labelled as overweight, and this includes 890 million individuals dealing with obesity. Among adults, 43% were overweight, and 16% were dealing with obesity. Also, 37 million children under 5 years of age were overweight, and over 390 million children and young people between 5 and 19 years of age were overweight, including 160 million dealing with obesity. Consequently, the escalating obesity rate is a major factor propelling the gestational diabetes market.
Which Companies Are Leading in the Gestational Diabetes Market?
Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc
What Are the Major Trends Shaping the Acellular Dermal Matrices Market?
Key players in the gestational diabetes market are concentrating their efforts on innovating technologically superior products like diagnostic kits for gestational diabetes. These innovations aim to ensure speedy, precise, and easy-to-use methods for early detection. Diagnostic kits for this type of diabetes act as medical instruments for assessing blood glucose levels and identifying abnormal glucose tolerance in pregnant women, which allows the timely diagnosis and treatment of the illness. A case in point is the XpressGT RUO kit launched by DirectSens GmbH, a biotechnology firm based in Austria, in August 2024. This diagnostic kit, specifically designed for diagnosing gestational diabetes, endometriosis, insulin resistance, and liver disease, efficiently records 2-hydroxybutyrate (2-HB) levels found in venous blood, which are typically generated by the liver during its regular functions. High levels of 2-HB are connected with augmented reductive stress, which is related to various endocrine and obesity-related disorders, including insulin resistance. The kit can be used with any existing clinical analyzer and delivers results in as short as 8 minutes, thereby providing a speedy and effective diagnostic solution.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report
What Are the Top Revenue-Generating Geographies in the Gestational Diabetes Market?
North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gestational Diabetes Market?
2. What is the CAGR expected in the Gestational Diabetes Market?
3. What Are the Key Innovations Transforming the Gestational Diabetes Industry?
4. Which Region Is Leading the Gestational Diabetes Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gestational Diabetes Market Size Projected To Reach 12.9 Billion By 2034 With A Cagr Of 9% here
News-ID: 4067153 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
